Sub-Clinical Atrial Fibrillation Biomarker Study

Active, not recruitingOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

June 26, 2017

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Subclinical Atrial Fibrillation
Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
collaborator

Population Health Research Institute

OTHER

collaborator

Genome Canada

OTHER

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Pfizer

INDUSTRY

collaborator

Medtronic

INDUSTRY

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Ottawa Heart Institute Research Corporation

OTHER